LambdaVision is a biotechnology company that develops a protein-based artificial retina to restore vision for patients.
LambdaVision has raised $7.0M in total funding. The most recent round was Seed. The last funding was announced in November 2025.
LambdaVision's investors include National Science Foundation, Seven Seven Six, Connecticut Innovations, Seraphim Space, MassChallenge.
LambdaVision is headquartered in Farmington, United States.
LambdaVision is a biotechnology company that develops a protein-based artificial retina to restore vision for patients.
LambdaVision is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"LambdaVision — Funding & Investors." VCBacked, November 5, 2025, https://www.vcbacked.co/company/lambdavision. Accessed July 19, 2026.
VCBacked. (2025). LambdaVision — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/lambdavision
{{cite web |title=LambdaVision — Funding & Investors |url=https://www.vcbacked.co/company/lambdavision |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated